Faes Farma to acquire SIFI.

Faes Farma, a European pharmaceutical company, agreed to acquire SIFI, an international ophthalmic company. Financial terms were not disclosed. "We are impressed with the strength of SIFI's business model and the capabilities of its management team. This transaction strengthens our position in ophthalmology, a therapeutic area with significant growth potential, and accelerates our international expansion with direct access to new markets in Europe. We look forward to working with Fabrizio Chines and SIFI's management team to fulfill our commitment to an innovative and more global ophthalmic franchise, offering a broader range of solutions aligned with the needs of professionals and patients and our common ambitions," Eduardo Recoder de la Cuadra, Faes Farma CEO.